Alternative FDG-PET relative standardized uptake value metrics for the assessment of early metabolic biomarkers of Alzheimer's disease

用于评估阿尔茨海默病早期代谢生物标志物的替代 FDG-PET 相对标准化摄取值指标

• 批准号: 293585
• 负责人: Darvesh Sultan
• 金额: $ 7.25万
• 依托单位: Dalhousie University (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-10-01 至 2015-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=293585&lang=en
• 关键词: 11c Pib; 18f Florbetapir; 18f-Fdg-Pet Imaging; Alzheimer'S Disease; Alzheimer'S Disease Neuroimaging Initiative; Glucose Metabolism; Mild Cognitive Impairment; Relative Standardized Uptake Values

Alzheimer's disease (AD) is a degenerative brain disorder causing dementia. Treatments to slow or reverse AD are unrealized as are the means for early definitive disease diagnosis. The brain relies on glucose metabolism for many functions and, with radioa

阿尔茨海默病（AD）是一种引起痴呆的退行性脑疾病。减缓或逆转AD的治疗尚未实现，早期明确疾病诊断的手段也未实现。大脑的许多功能都依赖于葡萄糖代谢，